Heron Therapeuti
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 4,575.2% | 2.7% | 32.7% | 11.9% | 12.3% | 13.3% | 27.1% | 30.3% | 38.3% | 40.1% | 47.3% | 37.1% | 40.3% | 45.2% | 41.8% | 39.7% | 35.9% | 45.6% | 46.0% | 64.7% | 48.9% | 53.0% | 48.4% | 58.5% | 55.4% | 42.1% | 56.9% | 63.5% | 57.9% | 28.9% | 24.4% | 29.2% | 28.8% | 25.1% | 21.7% | 26.5% | 40.3% | 18.8% | 30.6% | 30.7% | 29.9% | |
| -46.0% | 97.3% | 67.3% | 88.1% | 87.7% | 86.7% | 72.9% | 69.7% | 61.7% | 59.9% | 52.7% | 62.9% | 59.7% | 54.8% | 58.2% | 60.3% | 64.1% | 54.4% | 54.0% | 35.3% | 51.1% | 47.0% | 51.6% | 41.5% | 44.6% | 57.9% | 43.1% | 36.5% | 42.1% | 71.1% | 75.6% | 70.8% | 71.2% | 74.9% | 78.3% | 73.5% | 59.7% | 81.2% | 69.4% | 69.3% | 70.1% | |
| 4,575.2% | 2,306.9% | 919.2% | 336.0% | 336.5% | 475.1% | 342.0% | 174.6% | 153.8% | 138.3% | 136.0% | 113.0% | 81.4% | 137.6% | 145.3% | 194.1% | 246.3% | 215.7% | 190.4% | 157.0% | 123.1% | 139.8% | 179.3% | 104.4% | 96.2% | 36.8% | 29.8% | 41.6% | 43.1% | 32.0% | 13.3% | 12.3% | 13.6% | 7.8% | 5.9% | 7.9% | 9.1% | 9.2% | 6.9% | 7.2% | 8.1% | |
| 806.8% | 460.7% | 185.6% | 72.7% | 75.4% | 61.3% | 60.8% | 35.9% | 36.8% | 30.3% | 30.5% | 26.7% | 20.2% | 28.1% | 41.0% | 43.3% | 47.5% | 60.7% | 47.8% | 48.6% | 42.1% | 47.9% | 40.6% | 33.2% | 36.9% | 29.7% | 53.5% | 61.7% | 37.0% | 33.0% | 43.2% | 38.6% | 37.7% | 29.8% | 32.7% | 38.9% | 36.6% | 33.1% | 35.0% | 29.9% | 33.6% | |
| 7,221.5% | 3,756.6% | 1,424.7% | 582.3% | 569.7% | 702.3% | 522.4% | 294.6% | 272.9% | 237.8% | 257.4% | 204.2% | 141.4% | 224.0% | 265.8% | 306.2% | 356.5% | 351.9% | 314.3% | 304.7% | 273.7% | 306.2% | 319.8% | 220.6% | 202.3% | 125.7% | 154.7% | 170.0% | 121.4% | 101.0% | 89.5% | 88.7% | 84.8% | 64.7% | 70.2% | 77.9% | 70.5% | 81.1% | 83.1% | 74.7% | 77.3% | |
| -7,221.5% | -3,659.3% | -1,357.4% | -494.2% | -482.0% | -615.6% | -449.5% | -224.9% | -211.2% | -177.9% | -204.7% | -141.2% | -81.8% | -169.2% | -207.6% | -245.9% | -292.4% | -297.5% | -260.3% | -269.4% | -222.6% | -259.2% | -268.2% | -179.1% | -157.7% | -67.8% | -111.6% | -133.5% | -79.3% | -29.9% | -13.8% | -17.9% | -13.6% | 10.2% | 8.1% | -4.4% | -10.7% | 0.1% | -13.7% | -5.4% | -7.2% | |
| 117.2% | 231.2% | 28.4% | 8.7% | 6.4% | 16.0% | 6.9% | 4.6% | 2.5% | 9.3% | 0.9% | 1.1% | 0.9% | 4.2% | – | – | – | 9.2% | – | – | – | 11.7% | 4.1% | 24.8% | 0.1% | 8.2% | 1.0% | 1.8% | 1.8% | 6.3% | 1.6% | 1.1% | 1.5% | 10.9% | 1.3% | 1.3% | 7.6% | 2.5% | – | – | – | |
| -7,338.7% | -3,750.0% | -1,385.7% | -502.9% | -488.4% | -621.6% | -451.8% | -223.8% | -193.8% | -171.8% | -199.4% | -137.0% | -78.8% | -165.1% | -203.1% | -243.5% | -291.7% | -302.3% | -262.8% | -271.9% | -225.6% | -264.6% | -272.4% | -204.0% | -157.8% | -66.2% | -110.6% | -132.4% | -79.6% | -31.3% | -9.1% | -25.6% | -14.8% | 9.0% | 6.8% | -6.4% | -45.8% | -7.3% | -23.4% | -14.6% | -22.5% | |
| 0.0% | -23.9% | 0.0% | 0.0% | 0.0% | 10.1% | 0.0% | 0.0% | 0.0% | -1.5% | – | – | – | -1.6% | – | – | – | -3.5% | – | – | – | -11.7% | 4.1% | 24.8% | 0.1% | 24.4% | -1.0% | 1.9% | 2.4% | 0.9% | 1.9% | – | – | – | – | – | – | – | – | – | – | |
| -7,338.7% | -3,750.0% | -1,385.7% | -502.9% | -488.4% | -621.6% | -451.8% | -223.8% | -193.8% | -171.8% | -199.4% | -137.0% | -78.8% | -165.1% | -203.1% | -243.5% | -291.7% | -302.3% | -262.8% | -271.9% | -225.6% | -264.6% | -272.4% | -204.0% | -157.8% | -66.2% | -110.6% | -132.4% | -79.6% | -31.3% | -9.1% | -25.6% | -14.8% | 9.0% | 6.8% | -6.4% | -45.8% | -7.3% | -23.4% | -14.6% | -22.5% | |
| -7,175.5% | -3,601.3% | -1,348.3% | -489.3% | -477.2% | -611.8% | -446.2% | -223.0% | -209.2% | -149.5% | -203.3% | -139.9% | -80.5% | -146.5% | -205.2% | -242.7% | -288.6% | -280.5% | -256.6% | -268.6% | -222.4% | -257.5% | -269.3% | -201.5% | -155.1% | -81.4% | -108.2% | -130.1% | -75.5% | -16.3% | -5.5% | -22.7% | -11.5% | 21.4% | 9.5% | -4.8% | -36.6% | -2.0% | -21.8% | -14.6% | -18.4% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.